Fiona Robinson: New Ways to Engage Young People with Bleeding Disorders on the Upcoming NBDF Wednesday Webinar
Fiona Robinson, Consultant, Medical Writing and Editing, at Communications Fiona Robinson, reposted from NBDF on LinkedIn:
”Looking for a tool to open discussion with young bleeding disorders community members about their hopes and fears?
This week’s National Bleeding Disorders Foundation Wednesday Webinar features a special reading and discussion about the graphic novel designed for this purpose: ‘Stellar Guardians.’
Sponsored by Genentech, this webinar will only be available as a live Zoom, so make sure you pre-register and join via Zoom!
Wed, June 17, 2PM ET”
Quoting National Bleeding Disorders Foundation (NBDF)‘s post:
”What happens when confidence, adventure, and hemophilia awareness come together?
Join us for a special reading and discussion of ‘Stellar Guardians,’ a graphic novel following young hero Sam Atlas on an epic space mission inspired by real members of the bleeding disorders community.
This engaging webinar is designed to encourage confidence, self-advocacy, and connection for kids with hemophilia A and their families.
Sponsored by Genentech.
Stay updated with Hemostasis Today.
-
Jun 16, 2026, 13:56Christina (Tina) P.: Can Vitamin K Help Stabilize Your INR?
-
Jun 16, 2026, 13:49Tomáš Šimurda: Fibromics Team Secures EHA Innovation Grant for Innovative Research
-
Jun 16, 2026, 13:47Kaziwa Rasoul: Understanding Thrombosis in PNH
-
Jun 16, 2026, 13:31Updated Recommendations for Pediatric Antithrombotic Therapies – JTH
-
Jun 16, 2026, 13:28Vidya Rajbhoj: Sharing Our Work on Developing an FND Pathway for Stroke Patients at FNDS 2026
-
Jun 16, 2026, 13:21Vinu Rajendran: Donor Appreciation Evening – World Blood Donor Day 2026
-
Jun 16, 2026, 13:21Robin Wells: Coming Together o Support the American Heart Association’s Detroit Heart and Stroke Walk
-
Jun 16, 2026, 13:07Dimitris Nikolopoulos: Summer Vacation Can Increase Your Risk for Deep Vein Thrombosis
-
Jun 16, 2026, 13:06Toyosi Onwuemene: Why Anticoagulation Errors Persist Despite Strong Protocols